[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:granulosa-cell-ovarian-cancer":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Granulosa Cell Ovarian Cancer",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04449549","Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel",[11],"Phase 2","RECRUITING","2026-08-26T02:18:19.586423Z","2026-05-05T02:43:29.402368Z",[],[]]